Prognostic significance of C-reactive protein to albumin ratio in colorectal cancer patients: a meta-analysis
- 66 Downloads
Inconsistent results on the prognostic significance of C-reactive protein to albumin ratio (CAR) in colorectal cancer patients have been reported. This meta-analysis sought to assess the prognostic value of pretreatment CAR for survival outcomes in colorectal cancer patients.
We conducted a systematic literature search of PubMed and Embase databases until February 16, 2019. Observational studies investigating the prognostic role of pretreatment CAR for survival outcome in patients with colorectal cancer were included. Outcome measures included overall survival (OS), disease-free survival (DFS), or progression-free survival (PFS). Pooled hazard ratio (HR) with 95% confidence interval (CI) was utilized to summarize the prognostic significance of CAR for patient survival.
Nine retrospective studies involving 2492 colorectal cancer patients were identified. A fixed-effect model meta-analysis showed that high pretreatment CAR was an independent predictor of poor OS (HR 2.25; 95% CI 1.84–2.76) and DFS (HR 2.49; 95% CI 1.43–4.33). On the other hand, no significant association was observed between high CAR and PFS (HR 1.71; 95% CI 0.44–6.60). The predictive values of OS with high pretreatment CAR caused no significant changes in different sample sizes, countries, cut-off values of CAR, treatment methods, and study quality of subgroups.
This meta-analysis suggests that CAR may be a powerful prognostic indicator for colorectal cancer prognosis. High pretreatment CAR is associated with poor OS and DFS in patients with colorectal cancer.
KeywordsC-reactive protein/albumin ratio Colorectal cancer Disease-free survival Overall survival Meta-analysis
This work was supported by (1) Jiangsu Provincial Key Research and Development Special Fund (BE2015666), (2) Jiangsu Innovative Team Leading Talent Fund (CXTDC2016006, QNRC2016446), (3) Natural Science Foundation of Jiangsu (BK20171304), (4) Jiangsu Six High Peak Talent Fund (WSW-205), and (5) Jiangsu 333 Talent Fund (BRA2016140).
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
This article does not contain any studies with human participants or animals performed by any of the authors.
No informed consent.
- 3.Molinari C, Marisi G, Passardi A, Matteucci L, De Maio G, Ulivi P (2018) Heterogeneity in colorectal cancer: a challenge for personalized medicine? Int J Mol Sci 19(12) pii: E3733 https://doi.org/10.3390/ijms19123733
- 8.Shibutani M, Maeda K, Nagahara H, Iseki Y, Ikeya T, Hirakawa K (2016) Prognostic significance of the preoperative ratio of C-reactive protein to albumin in patients with colorectal cancer. Anticancer Res 36(3):995–1001Google Scholar
- 9.Shibutani M, Maeda K, Nagahara H, Iseki Y, Hirakawa K, Ohira M (2016) The significance of the C-reactive protein to albumin ratio as a marker for predicting survival and monitoring chemotherapeutic effectiveness in patients with unresectable metastatic colorectal cancer. SpringerPlus 5(1):1798CrossRefGoogle Scholar
- 12.Ide S, Toiyama Y, Okugawa Y, Oki S, Yasuda H, Fujikawa H, Yoshiyama S, Hiro J, Kobayashi M, Ohi M, Araki T, Kusunoki M (2017) Clinical significance of C-reactive protein-to-albumin ratio with rectal cancer patient undergoing chemoradiotherapy followed by surgery. Anticancer Res 37(10):5797–5804Google Scholar
- 14.Shibutani M, Nagahara H, Fukuoka T, Iseki Y, Matsutani S, Wang EN, Maeda K, Hirakawa K, Ohira M (2019) Prognostic significance of the C-reactive protein-to-albumin ratio in patients with metastatic colorectal cancer treated with trifluridine/thymidine phosphorylase inhibitor as later-line chemotherapy. Anticancer Res 39(2):1051–1057CrossRefGoogle Scholar
- 16.Wells G, Shea B, O'Connell D, Peterson J, Welch V, Losos M, Tugwell P The Newcastle-Ottawa scale (NOS) for assessing the quality if nonrandomized studies in meta-analyses. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed 20 Feb 2019
- 19.Ni XF, Wu P, Wu J, Ji M, Shao YJ, Zhou WJ, Jiang JT, Wu CP (2016) C-reactive protein/albumin ratio as a predictor of survival of metastatic colorectal cancer patients receiving chemotherapy. Int J Clin Exp Pathol 9(5):5525–5534Google Scholar